OSAS (Obstructive Sleep Apneas Syndrome): Clinical Trials

5 trials for OSAS (Obstructive Sleep Apneas Syndrome), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 enrolling by invitation, 1 not yet recruiting, 1 unknown. 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Not yet recruiting 1
Phase 31Unknown 1

Follow OSAS (Obstructive Sleep Apneas Syndrome): new trials by email Literature Review of OSAS (Obstructive Sleep Apneas Syndrome) trials Research Report on OSAS (Obstructive Sleep Apneas Syndrome)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Use of Remimazolam Versus Dexmedetomidine for Patients Receiving Drug-Induced Sleep Endoscopy
Remimazolam, Dexmedetomidine - OSAS (Obstructive Sleep Apneas Syndrome), DISE
Not applicableNot yet recruitingFu Jen Catholic University Hospital602026-08-052026-08-12
MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study
MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, Cirrhosis
Enrolling by invitationLinkoeping University3172025-12-162026-10-09
Immune Status and Disease Control of Inflammatory Airway Diseases
Airway Inflammation, Chronic Obstructive Pulmonary Disease (COPD)
RecruitingFirst Affiliated Hospital of Ningbo University2002025-08-012026-03-25
The Outcome of Chronic Kidney Disease Patients With Obstructive Sleep Apnea Syndrome
No intervention - Chronic Kidney Diseases, OSAS (Obstructive Sleep Apneas Syndrome)
RecruitingNanfang Hospital, Southern Medical University3562025-07-172025-11-17
ISIS 1 Therapeutic Effectiveness
titration night - OSAS (Obstructive Sleep Apneas Syndrome)
Phase 3UnknownTyco Healthcare Group242007-10-012008-03-28

Narrower conditions

Sleep Apnea, Obstructive (5)  ·  Aspergillosis, Allergic Bronchopulmonary (1)  ·  Asthma (1)  ·  Bronchiectasis (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Disease (1)  ·  Fibrosis (1)  ·  Hypertension (1)  ·  Metabolic Syndrome (1)  ·  Obesity (1)  ·  Overweight (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Renal Insufficiency, Chronic (1)  ·  Sarcopenia (1)

Broader conditions

Apnea (5)  ·  Dyssomnias (5)  ·  Nervous System Diseases (5)  ·  Respiration Disorders (5)  ·  Respiratory Tract Diseases (5)  ·  Sleep Apnea Syndromes (5)  ·  Sleep Disorders, Intrinsic (5)  ·  Sleep Wake Disorders (5)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Chronic Disease (2)  ·  Disease Attributes (2)  ·  Aspergillosis (1)  ·  Atrophy (1)  ·  Bacterial Infections and Mycoses (1)

Interventions

Dexmedetomidine (1)  ·  remimazolam (1)

Sponsors

First Affiliated Hospital of Ningbo University (1)  ·  Fu Jen Catholic University Hospital (1)  ·  Linkoeping University (1)  ·  Nanfang Hospital, Southern Medical University (1)  ·  Tyco Healthcare Group (1)

Countries

China (2)  ·  France (1)  ·  Sweden (1)  ·  Taiwan (1)

Top investigators

Patrik Nasr, M.D., Ph.D. (1)  ·  Veronique Grillier-Lanoir (1)